Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study. Although DLB is the second most common neurodegenerative dementia following Alzheimer's ...

The Journal of the Alzheimer's Association highlights the new Alzheimer's Association Clinical Practice Guideline for the Diagnostic Evaluation, Testing, Counseling and Disclosure of Suspected ...

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in ...

It is believed most humans are ... First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step Closer Dec. 19, 2024 — Phase I clinical trial of a drug was successfully ...

The Alzheimer’s Association has updated its guidelines for diagnosing dementia, leaving them broad but giving room to integrate new and upcoming developments in dementia diagnosis. It’s the ...

A new Alzheimer’s treatment has shown unprecedented success in late-stage clinical trials, offering hope to millions of patients and their families worldwide. The drug, developed by a collaboration ...

Opens in a new tab or window Two clinical trials investigating semaglutide (Ozempic, Wegovy) as an early Alzheimer's treatment are ... issued a clinical practice guideline on evaluating, testing ...

Dopamine’s involvement in Alzheimer’s treatment stems from its ability to stimulate the production of neprilysin, an enzyme crucial for breaking down beta-amyloid. Neprilysin acts as a natural ...